Case Report: Osteosynthesis-associated infection with Ochrobactrum intermedium after acetabular fracture

<i>Ochrobactrum intermedium</i> (<i>O. intermedium</i>) is a gram-negative, non-fermenting bacterium closely related to <i>Brucella</i> genus. <i>O. intermedium</i> resembles an emergent human pathogen that has rarely been detected in both immunocompetent and immunodeficient patients. A musculoskeletal infection with <i>O. intermedium</i> has not been described in the literature. We present the first case of an osteosynthesis-associated infection (OAI) with <i>O. intermedium</i> in an 80-year-old female patient after osteosynthesis of an acetabular fracture. The patient was admitted to the emergency department 6 months after osteosynthesis of a posterior column acetabular fracture treated via open reduction and internal plate fixation of the posterior column. The patient demonstrated tenderness, redness and swelling at the insertion site as well as a fistula. The radiological controls showed femoral head necrosis and partial protrusion of the head into the pelvis. The laboratory parameters showed no pathological findings. OAI was assumed and a two-stage revision with implant removal and resection arthroplasty in the first stage and hip arthroplasty in the second stage was performed. All microbiological specimens taken at the osteosynthesis site and the hip joint grew <i>O. intermedium</i>. The pathogen was determined using the matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) method. Antibiotic regime consisted of intravenous (IV) meropenem for two weeks followed by oral ciprofloxacin and cotrimoxazole. Implantation of the hip prosthesis was performed 6 weeks after the index surgery using a cementless revision cup and a cemented stem. Meropenem and vancomycin IV were given for one week followed by ciprofloxacin and doxycycline for another 5 weeks. 24 months after the surgery, the patient is infection free and satisfied with the result. With this case report we would like to increase awareness of possible implant-associated bacterial infections caused by <i>O. intermedium</i>.

Authors

Institutions

Publication Details

Journal
Frontiers in Surgery
Published
2024-10-25
DOI
https://doi.org/10.3389/fsurg.2024.1382564
Citations
1
Primary Topic
Infections and bacterial resistance
Type
article
Field-Weighted Citation Impact
0.62
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Case Report: Osteosynthesis-associated infection with Ochrobactrum intermedium after acetabular fracture

Andrej Trampuž, Karl-Dieter Heller, S.G.M. Weenders, David R. Krueger
1 citations
Frontiers in Surgery
Infections and bacterial resistance
0.62
article

Case Report: Osteosynthesis-associated infection with Ochrobactrum intermedium after acetabular fracture

Andrej Trampuž, Karl-Dieter Heller, S.G.M. Weenders, David R. Krueger
article en
1 citations

Abstract

<i>Ochrobactrum intermedium</i> (<i>O. intermedium</i>) is a gram-negative, non-fermenting bacterium closely related to <i>Brucella</i> genus. <i>O. intermedium</i> resembles an emergent human pathogen that has rarely been detected in both immunocompetent and immunodeficient patients. A musculoskeletal infection with <i>O. intermedium</i> has not been described in the literature. We present the first case of an osteosynthesis-associated infection (OAI) with <i>O. intermedium</i> in an 80-year-old female patient after osteosynthesis of an acetabular fracture. The patient was admitted to the emergency department 6 months after osteosynthesis of a posterior column acetabular fracture treated via open reduction and internal plate fixation of the posterior column. The patient demonstrated tenderness, redness and swelling at the insertion site as well as a fistula. The radiological controls showed femoral head necrosis and partial protrusion of the head into the pelvis. The laboratory parameters showed no pathological findings. OAI was assumed and a two-stage revision with implant removal and resection arthroplasty in the first stage and hip arthroplasty in the second stage was performed. All microbiological specimens taken at the osteosynthesis site and the hip joint grew <i>O. intermedium</i>. The pathogen was determined using the matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) method. Antibiotic regime consisted of intravenous (IV) meropenem for two weeks followed by oral ciprofloxacin and cotrimoxazole. Implantation of the hip prosthesis was performed 6 weeks after the index surgery using a cementless revision cup and a cemented stem. Meropenem and vancomycin IV were given for one week followed by ciprofloxacin and doxycycline for another 5 weeks. 24 months after the surgery, the patient is infection free and satisfied with the result. With this case report we would like to increase awareness of possible implant-associated bacterial infections caused by <i>O. intermedium</i>.

Frontiers in SurgeryVol. 11
Charité - Universitätsmedizin Berlin (DE)
Zero hunger
Openalex Percentile: Top 27%
Infections and bacterial resistance
0.62
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.